Cord Blood Derived Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cord Blood Derived Mesenchymal Stem Cells, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia [Phase 1, Phase 2]